Last update:

Immunology news

Oncology & Cancer

Study identifies biomarker that could predict whether colon cancer patients benefit from chemotherapy

Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy following surgery. However, clinical trials have shown that this treatment doesn't improve the chances of survival for every patient. ...

Neuroscience

Central nervous system-associated macrophages could modulate post-stroke immune responses

An ischemic stroke is a type of stroke that occurs when a blood clot in an artery, also known as thrombus, or the progressive narrowing of arteries, blocks the blood and oxygen flowing to the brain. This process can cause ...

Diseases, Conditions, Syndromes

Scientists identify key protein behind spread of shingles virus

Scientists at the University of Colorado Anschutz Medical Campus have discovered a new evasion strategy used by the varicella zoster virus, which causes chickenpox and shingles, that may allow it to affect tissues far from ...

Immunology

T cells and aging: Unraveling the complexities of lifespan

Aging significantly impacts the immune system, notably through the involution of the thymus, which reduces T cell production. This decline weakens immune responses, making older adults more susceptible to infections and diseases. ...

Immunology

Newly identified immune cell switch could control inflammation

Cornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help clinicians control inflammation-related conditions such as autoimmune, cardiovascular ...

Alzheimer's disease & dementia

Unique neutrophil type associated with Alzheimer's disease identified

Researchers have identified a unique type of neutrophil significantly associated with Alzheimer's disease (AD) pathology and mapped the transcriptome of neutrophils in the peripheral blood of AD mice. The study was published ...

Oncology & Cancer

Blood test may guide use of multiple myeloma immunotherapy

A simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according ...